Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer – results from the prospective multi-center randomized ADEBAR trial

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Lukas Schwentner, Nadia Harbeck, Susanne Singer, Martin Eichler, Brigitte Rack, Helmut Forstbauer, Arthur Wischnik, Christoph Scholz, Jens Huober, Thomas W. P. Friedl, Tobias Weissenbacher, Kristin Härtl, Marion Kiechle, Wolfgang Janni, Visnja Fink
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/122819
ISSN:0960-9776OPAC
Parent Title (English):The Breast
Publisher:Elsevier BV
Place of publication:Amsterdam
Type:Article
Language:English
Year of first Publication:2016
Release Date:2025/07/10
Volume:27
First Page:69
Last Page:77
DOI:https://doi.org/10.1016/j.breast.2016.03.003
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum

OPUS4 Logo